2024 annual financial data
Addex Therapeutics 2024 Operating margin
Direct answer
Operating margin was -681.82%.
Operating income was -2,755,233 CHF and net income was 7,055,787 CHF.
Operating cash flow was -5,373,554 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 404,102 CHF
- Operating income
- -2,755,233 CHF
- Net income
- 7,055,787 CHF
- Operating cash flow
- -5,373,554 CHF